Maze Therapeutics
South San Francisco
About Maze Therapeutics
Maze Therapeutics is a biotechnology company focused on developing medicines that mimic the effects of rare, protective genetic variants to address unmet medical needs. Utilizing its Compass platform, the company identifies genetic variants associated with diseases and maps them to the biological pathways driving these conditions in specific patient populations.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $100K – $500K
- Total funding: $646.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Sep 2025)
- Ticker: nasdaq:MAZE
- Website: mazetx.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Genetics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/maze-therapeutics-80846 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.